000 01417 a2200409 4500
005 20250515015719.0
264 0 _c20060426
008 200604s 0 0 eng d
022 _a1525-8882
024 7 _a10.1126/stke.3242006pe9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuthridge, Mark A
245 0 0 _aMeeting report: Barossa 2005--Signaling Networks.
_h[electronic resource]
260 _bScience's STKE : signal transduction knowledge environment
_cFeb 2006
300 _ape9 p.
_bdigital
500 _aPublication Type: Congress
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGenes, erbB-2
650 0 4 _aHumans
650 0 4 _aLipids
_xphysiology
650 0 4 _aLiver Neoplasms, Experimental
_xchemically induced
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aNeoplasm Proteins
_xphysiology
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aRNA
_xphysiology
650 0 4 _aReceptors, Cell Surface
_xphysiology
650 0 4 _aSignal Transduction
_xphysiology
650 0 4 _aSphingosine
_xphysiology
650 0 4 _aStem Cells
_xphysiology
700 1 _aGoodall, Gregory J
700 1 _aPitson, Stuart M
773 0 _tScience's STKE : signal transduction knowledge environment
_gvol. 2006
_gno. 324
_gp. pe9
856 4 0 _uhttps://doi.org/10.1126/stke.3242006pe9
_zAvailable from publisher's website
999 _c16118276
_d16118276